Ganciclovir: all 74 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and IINot yet recruitingNCT07513623Phase 2
- Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic RhinitisRecruitingNCT06436534Not applicable
- Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus RetinitisRecruitingNCT05911503Early Phase 1
- Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and SepsisTerminatedNCT04706507Phase 3Results posted
- Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment OutcomesTerminatedNCT03586284Phase 2/3Results posted
- Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster KeratitisTerminatedNCT02382588Phase 2Results posted
- Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory FailureCompletedNCT01335932Phase 2Results posted
- Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow TransplantCompletedNCT00530218Phase 2Results posted
- Islet Transplantation for Type 1 DiabetesCompletedNCT00014911Phase 2Results posted
- Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)CompletedNCT00000136Phase 3Results posted
- Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic KeratitisCompletedNCT06757907Not applicable
- Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidCompletedNCT05578820Phase 1
- Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus InfectionStatus unknownNCT04225780Phase 1/2
- Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.CompletedNCT03699254Phase 3
- High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative PatientsCompletedNCT03598452Not applicable
- CMV-CTL for the Treatment of CMV Infection After HSCTCompletedNCT03004261Phase 4
- Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02202564Phase 2
- PTH - Preemptive Treatment for HerpesviridaeCompletedNCT02152358Phase 4
- Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / EndotheliitisCompletedNCT01647529Not applicable
- Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by AdenovirusStatus unknownNCT01600365Phase 3
- A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus ConjunctivitisCompletedNCT01533480Phase 4
- Cytomegalovirus Control in Critical CareCompletedNCT01503918Phase 2
- Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus KeratoconjuntivitisCompletedNCT01349452Not applicable
- Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell TransplantationTerminatedNCT01185223Phase 3
- A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic CancersCompletedNCT00964756Phase 1
- Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)CompletedNCT00947141Phase 4
- Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid MalignanciesTerminatedNCT00917826Phase 2
- Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantCompletedNCT00716911Not applicable
- VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant RecipientsCompletedNCT00431353Phase 4
- Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft RecipientsCompletedNCT00373165Phase 4
- Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement TherapyTerminatedNCT00264368Phase 4
- Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell TransplantTerminatedNCT00241345Phase 3
- Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive LymphomaTerminatedNCT00093704Phase 1
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusCompletedNCT00006340Phase 1
- Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System LymphomaCompletedNCT00006264Phase 2
- Vaccine Therapy and Ganciclovir in Treating Patients With MesotheliomaStatus unknownNCT00006216Phase 1
- Gene Therapy and Ganciclovir in Treating Patients With Stage IV MelanomaCompletedNCT00005057Phase 1
- Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCRStatus unknownNCT00004573Not applicable
- Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus InfectionCompletedNCT00004278Phase 3
- A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the EyesCompletedNCT00002377Phase 3
- A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002330Not applicable
- The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002299Not applicable
- A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDSCompletedNCT00002273Not applicable
- A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSCompletedNCT00002257Not applicable
- A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral GanciclovirCompletedNCT00002251Not applicable
- A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyCompletedNCT00002247Not applicable
- A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )CompletedNCT00002156Phase 2
- An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous AccessCompletedNCT00002135Not applicable
- A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus RetinitisCompletedNCT00002134Not applicable
- A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineCompletedNCT00002096Phase 1
- A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusCompletedNCT00002095Not applicable
- Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV RetinitisCompletedNCT00002070Phase 3
- A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDSCompletedNCT00002034Not applicable
- Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised PatientCompletedNCT00002025Not applicable
- Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus InfectionsCompletedNCT00002024Not applicable
- An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in ChildrenCompletedNCT00002015Not applicable
- A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDSCompletedNCT00001999Not applicable
- Gene Therapy for the Treatment of Brain TumorsCompletedNCT00001328Phase 1
- A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.CompletedNCT00001100Phase 3
- A Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesCompletedNCT00001062Phase 1
- The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCompletedNCT00001034Phase 2
- A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionCompletedNCT00000995Not applicable
- The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDSCompletedNCT00000989Not applicable
- A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirCompletedNCT00000970Phase 1
- Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisCompletedNCT00000894Phase 4
- A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.WithdrawnNCT00000856Phase 1
- A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus DiseaseCompletedNCT00000805Phase 1
- A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedNCT00000768Phase 1
- A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV RetinitisCompletedNCT00000698Phase 3
- A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDSCompletedNCT00000688Phase 3
- A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic TherapyCompletedNCT00000673Phase 1
- A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral GanciclovirCompletedNCT00000668Phase 1
- Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir ComponentCompletedNCT00000665Not applicable